BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22951153)

  • 1. Decreased interferon-α and interferon-β production in obesity and expression of suppressor of cytokine signaling.
    Teran-Cabanillas E; Montalvo-Corral M; Caire-Juvera G; Moya-Camarena SY; Hernández J
    Nutrition; 2013 Jan; 29(1):207-12. PubMed ID: 22951153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of interferon α and β, pro-inflammatory cytokines and the expression of suppressor of cytokine signaling (SOCS) in obese subjects infected with influenza A/H1N1.
    Terán-Cabanillas E; Montalvo-Corral M; Silva-Campa E; Caire-Juvera G; Moya-Camarena SY; Hernández J
    Clin Nutr; 2014 Oct; 33(5):922-6. PubMed ID: 24182768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway.
    Oshansky CM; Krunkosky TM; Barber J; Jones LP; Tripp RA
    Viral Immunol; 2009 Jun; 22(3):147-61. PubMed ID: 19435411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.
    Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
    Clin Exp Rheumatol; 2016; 34(1):100-5. PubMed ID: 26812031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders.
    Martinez D; Palmer C; Simar D; Cameron BA; Nguyen N; Aggarwal V; Lloyd AR; Zekry A
    Liver Int; 2015 Feb; 35(2):463-72. PubMed ID: 24461080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.
    Zimmerer JM; Lesinski GB; Kondadasula SV; Karpa VI; Lehman A; Raychaudhury A; Becknell B; Carson WE
    J Immunol; 2007 Apr; 178(8):4832-45. PubMed ID: 17404264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Leptin and SOCS3 in Inhibiting the Type I Interferon Response During Obesity.
    Terán-Cabanillas E; Hernández J
    Inflammation; 2017 Feb; 40(1):58-67. PubMed ID: 27704310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3.
    Park SJ; Kim TH; Jun YJ; Lee SH; Ryu HY; Jung KJ; Jung JY; Hwang GH; Lee SH
    J Allergy Clin Immunol; 2013 Mar; 131(3):772-80. PubMed ID: 23375208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
    Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
    Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients.
    Naz Z; Wahid B; Usman S; Saleem K; Rafique S; Ali A; Idrees M
    J Interferon Cytokine Res; 2018 Jun; 38(6):255-260. PubMed ID: 29920131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease].
    Liu YX; Wang H; Peng XY; Zhou ZC
    Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory Syncytial Virus Nonstructural Proteins Upregulate SOCS1 and SOCS3 in the Different Manner from Endogenous IFN Signaling.
    Zheng J; Yang P; Tang Y; Pan Z; Zhao D
    J Immunol Res; 2015; 2015():738547. PubMed ID: 26557722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.
    Lesinski GB; Zimmerer JM; Kreiner M; Trefry J; Bill MA; Young GS; Becknell B; Carson WE
    BMC Cancer; 2010 Apr; 10():142. PubMed ID: 20398276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS1 gene expression is increased in severe pulmonary tuberculosis.
    Masood KI; Rottenberg ME; Carow B; Rao N; Ashraf M; Hussain R; Hasan Z
    Scand J Immunol; 2012 Oct; 76(4):398-404. PubMed ID: 22670716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of Cytokine Signaling 3 Expression Induced by Varicella-Zoster Virus Infection Results in the Modulation of Virus Replication.
    Choi EJ; Lee CH; Shin OS
    Scand J Immunol; 2015 Oct; 82(4):337-44. PubMed ID: 26072679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.
    Demirel I; Säve S; Kruse R; Persson K
    APMIS; 2013 Feb; 121(2):158-67. PubMed ID: 23030674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
    Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
    Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells.
    Kanda N; Kamata M; Tada Y; Ishikawa T; Sato S; Watanabe S
    J Leukoc Biol; 2011 Jun; 89(6):935-44. PubMed ID: 21367976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbed Transcription of TLRs' Negative Regulators and Cytokines Secretion among TLR4- and 9-Activated PBMCs of Agammaglobulinemic Patients.
    Sanaei R; Rezaei N; Aghamohammadi A; Delbandi AA; Tavasolian P; Tajik N
    Immunol Invest; 2019 Nov; 48(8):860-874. PubMed ID: 31185757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling-1 Pathway for the Treatment of SLE.
    Sukka-Ganesh B; Larkin J
    Scand J Immunol; 2016 Nov; 84(5):299-309. PubMed ID: 27781323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.